Hem › Kronisk lymfatisk leukemi › District of Columbia › Washington
Kliniska studier för Kronisk lymfatisk leukemi i Washington, DC
22 studier för Kronisk lymfatisk leukemi söker deltagare vid platser i och runt Washington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekryterarFas 1/2
- American Oncology Partners of Maryland Pa, Bethesda · 7 mi bort
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
RekryterarFas 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · 7 mi bort
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi bort
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
RekryterarFas 3
- GC2202 Study Site 111, Bethesda · 7 mi bort
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RekryterarFas 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi bort
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
RekryterarFas 3
- American Oncology Partners of Maryland Pa, Bethesda · 7 mi bort
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RekryterarFas 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
RekryterarObservationsstudieFriska volontärer välkomna
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekryterarFas 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mi bort
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekryterarFas 2
- Maryland Oncology Hematology, Silver Spring · 7 mi bort
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
RekryterarTidig fas 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RekryterarFas 3
- American Oncology Partners of Maryland, PA, Bethesda · 7 mi bort
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
RekryterarFas 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · 7 mi bort
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
RekryterarFas 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekryterarFas 1
- National Institute of Health, Bethesda · 7 mi bort
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RekryterarFas 2
- American Oncology Partners, PA, Bethesda · 7 mi bort
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RekryterarObservationsstudieFriska volontärer välkomna
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
RekryterarFas 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · 7 mi bort
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · 7 mi bort
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RekryterarFas 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Kronisk lymfatisk leukemi-studier i andra städer
- Boston, MA31 studier
- Columbus, OH28 studier
- Durham, NC27 studier
- Seattle, WA20 studier
- Rochester, MN18 studier
- New York City, NY18 studier
- Houston, TX17 studier
- Baldwin Park, CA16 studier
- Milwaukee, WI15 studier
- Chicago, IL14 studier
- Cincinnati, OH14 studier
- Nashville, TN13 studier
Andra studier i Washington
- Cancer (alla typer)58 studier
- Icke-småcellig lungcancer55 studier
- Bröstcancer46 studier
- Metastaserande cancer43 studier
- Lungcancer41 studier
- Prostatacancer38 studier
- Övervikt33 studier
- Kolorektal cancer29 studier
- Hjärt-kärlsjukdom28 studier
- Blåscancer26 studier
- Akut myeloid leukemi24 studier
- Äggstockscancer23 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.